Skip to search boxSkip to navigationSkip to main content

Treatment of COPD exacerbations

Original title: KOAH alevlenmelerinin tedavisi: Farmakolojik seçenekler ve risk faktörlerinin modifikasyonu
*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Exacerbations of COPD are a major source of morbidity and mortality, resulting in tremendous increases in healthcare costs. Spirometric testing of atrisk persons can help identify patients early in the disease course who may benefit from early intervention to slow the disease process. Avoidance of irritants, smoking cessation, and use of pharmacologic agents aimed at decreasing airflow obstruction are strategies for reducing the frequency and severity of exacerbations. Patients should be educated about modifiable risk factors, such as ciagarette smoking, environmental exposures, improper inhaler technique, influenza and pneumonia vaccination, pulmonary rehabilitation, and use of supplemental oxygen. Early, aggressive interventions are necessary to improve quality of life, decrease hospital admissions, improve morbidity and mortality, and reduce overall healthcare costs.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

Turkish

Pages from-to (Number of pages)

Pages 40-46 (7 pages)

Journal (Volume, Issue Number)

SENDROM (Volume 15, Issue 7)

Publication milestones

  • Published - 07/2003

Publication status

Published - 07/2003

ISSN

1016-5134

Publication IDs

  • Scopus: 0142060059

Publication metrics

Metrics

Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
SciVal
Author count
1
SciVal
Paper percentile
24